Axon Enterprise
AXON
$351.33
-10.27%
Axon Enterprise, Inc. is a technology company building a public safety operating system by integrating a suite of hardware devices and cloud software solutions, including TASER energy devices, body cameras, drones, and digital evidence management platforms, operating within the Aerospace & Defense industry. The company is a dominant market leader and technology disruptor, uniquely positioned at the intersection of hardware, software, and data for law enforcement and public safety agencies globally. The current investor narrative is driven by its potential for explosive AI-driven growth, as highlighted by recent bullish commentary, but this is juxtaposed against significant recent stock price volatility and potential overhangs from broader tech sector privacy concerns impacting adjacent markets.…
AXON
Axon Enterprise
$351.33
Related headlines
Investment Opinion: Should I buy AXON Today?
Rating: Hold. The core thesis is that while Axon's long-term growth narrative in public safety AI is compelling, its extreme valuation, severe technical damage, and lack of consistent profitability create an unfavorable risk/reward profile at the current price, warranting a wait-and-see approach.
Supporting evidence includes an elevated trailing PS ratio of 16.43x and a forward EV/Sales of 11.98x, which price in significant future growth. While revenue growth is robust at 38.5% YoY, profitability is minimal with a 0.38% net margin. The stock trades near its 52-week low of $396.41, down 42.31% in six months, indicating intense selling pressure. Analyst sentiment is cautiously optimistic but coverage is limited to only 8 firms, suggesting specialized rather than broad conviction.
The thesis would upgrade to a Buy if the PS ratio compresses meaningfully below 12x (implying a price in the low $300s) alongside evidence of sustained margin expansion. It would downgrade to a Sell if revenue growth decelerates below 25% YoY or if the stock breaks decisively below the $396 support level on high volume. Relative to its own history and growth trajectory, the stock is fairly valued to slightly overvalued, as the current PS multiple near its historical midpoint already reflects its strong growth, leaving little room for multiple expansion.
Sign up to view all
AXON 12-Month Price Forecast
The outlook is balanced with high uncertainty. The bull case depends on a rapid improvement in profitability to catch up to the growth narrative, while the bear case is a continuation of the recent de-rating. The base case of volatile sideways action is most probable, as the stock digests its massive decline. The stance would upgrade to bullish on a confirmed breakout above $550 with volume, signaling the downtrend has broken. It would turn bearish on a weekly close below $390, confirming a breakdown from the current precarious support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Axon Enterprise's 12-month outlook, with a consensus price target around $456.73 and implied upside of +30.0% versus the current price.
Average Target
$456.73
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$281 - $457
Analyst target range
Analyst coverage is limited, with only 8 analysts providing estimates, indicating this is a stock with specialized institutional interest rather than broad coverage. The consensus sentiment leans bullish, as evidenced by recent institutional ratings from firms like RBC Capital ('Outperform'), Barclays ('Overweight'), and Morgan Stanley ('Overweight'), though UBS maintains a 'Neutral' stance. The average revenue estimate for the upcoming period is approximately $6.01 billion, with a tight range between $5.99B and $6.03B, signaling strong conviction in the near-term top-line forecast, but no explicit price target is provided in the data to calculate implied upside or downside. The range of analyst actions shows stability, with no rating changes in the most recent batch from late February 2026, suggesting a wait-and-see approach following the stock's precipitous decline. The implications of limited coverage are significant, as it can lead to higher volatility and less efficient price discovery, often characteristic of a story stock where narrative and long-term potential dominate near-term financial metrics, requiring investors to conduct deeper due diligence.
Bulls vs Bears: AXON Investment Factors
The evidence currently tilts bearish, primarily due to the stock's severe technical breakdown, extreme valuation multiples disconnected from current profitability, and volatile earnings profile. The bull case rests on a compelling long-term narrative of AI-driven growth in public safety and robust revenue expansion, but these prospects appear fully priced in. The single most important tension in the investment debate is whether the company's explosive revenue growth narrative can materialize quickly enough to justify its premium valuation before investor patience wears thin amid persistent profitability challenges. The resolution of this growth-to-profitability transition will determine the stock's direction.
Bullish
- Dominant Market Position & AI Narrative: Axon is a dominant market leader in public safety technology, uniquely integrating hardware and software. Recent bullish news highlights its potential for explosive AI-driven growth, with projections to triple revenue by 2028, creating a powerful long-term narrative.
- Robust Revenue Growth Trajectory: The company demonstrates strong top-line expansion, with Q4 2025 revenue of $796.7 million representing 38.5% year-over-year growth. Analyst consensus forecasts revenue of approximately $6.01 billion for the upcoming period, signaling high conviction in continued growth.
- Healthy Gross Margin Profile: Axon maintains a structurally sound gross margin of 57.9% (Q4 2025), which is healthy for its hardware-integrated SaaS model. This provides a solid foundation for future operating leverage as the business scales.
- Strong Balance Sheet & Liquidity: The company has a solid current ratio of 2.53 and a manageable debt-to-equity ratio of 0.59, providing financial flexibility. This strength is crucial for funding R&D and expansion during a period of volatile profitability.
Bearish
- Severe Technical Downtrend & Volatility: The stock is in a pronounced downtrend, down 42.31% over six months and 26.08% over the past year, underperforming the S&P 500 by 55.9 percentage points. With a beta of 1.605 and a maximum drawdown of -54.11%, it exhibits extreme volatility and selling pressure.
- Extremely High Valuation Multiples: Valuation metrics are stretched, with a trailing PS ratio of 16.43x, a forward EV/Sales of 11.98x, and an astronomical price-to-cash-flow ratio of 216.05. These multiples imply perfection in future execution and leave no margin for error.
- Inconsistent & Weak Profitability: Profitability is highly volatile and currently minimal, with Q4 2025 net income of just $3.0 million (net margin of 0.38%). Operating income has swung wildly from positive $24.4 million to negative $7.9 million in recent quarters, indicating poor cost control.
- Limited Analyst Coverage & Price Discovery: Only 8 analysts cover the stock, indicating specialized interest and potentially less efficient price discovery. This can exacerbate volatility and requires investors to conduct deeper, more independent due diligence.
AXON Technical Analysis
The stock is in a pronounced downtrend, having declined 26.08% over the past year and a staggering 42.31% over the last six months, with the current price of $412.81 sitting near the bottom of its 52-week range, at just 47% of the distance from its 52-week low of $396.41 to its high of $885.92. This positioning deep in the lower quartile of its annual range suggests the stock is either presenting a deep value opportunity or is a classic 'falling knife,' having failed to hold support levels after a severe correction from its highs. Recent momentum shows continued severe weakness, with the stock down 28.71% over the past month and 26.74% over the past three months, significantly underperforming the broader market as indicated by relative strength figures of -24.97 (1-month) and -22.74 (3-month). This persistent negative momentum, diverging from a market that is up 29.8% over the past year, signals intense selling pressure and a lack of near-term catalysts to arrest the decline. Key technical levels are clear, with immediate support at the 52-week low of $396.41 and major resistance far above near the 52-week high of $885.92; a breakdown below $396 would likely trigger another leg down, while any sustained recovery would face a long climb through multiple overhead resistance zones. The stock's beta of 1.605 confirms it is over 60% more volatile than the market, which, combined with a maximum drawdown of -54.11%, underscores the extreme risk and magnified price swings inherent in its current technical profile.
Beta
1.60
1.60x market volatility
Max Drawdown
-59.7%
Largest decline past year
52-Week Range
$347-$886
Price range past year
Annual Return
-37.2%
Cumulative gain past year
| Period | AXON Return | S&P 500 |
|---|---|---|
| 1m | -33.7% | +0.4% |
| 3m | -44.4% | -2.0% |
| 6m | -50.0% | +4.1% |
| 1y | -37.2% | +23.9% |
| ytd | -37.6% | -0.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXON Fundamental Analysis
Revenue growth remains robust but shows signs of volatility on a quarterly basis; the most recent Q4 2025 revenue was $796.7 million, representing a strong 38.5% year-over-year growth, though this follows a sequential decline from Q3's $710.6 million. The multi-quarter trend reveals impressive top-line expansion, with revenue growing from $459.9 million in Q1 2024 to the current level, but the path has been uneven, with Q4 2025 revenue notably higher than the $575.1 million reported in Q4 2024. Profitability is inconsistent and currently weak; the company reported net income of just $3.0 million in Q4 2025, resulting in a thin net margin of 0.38%, while the gross margin of 57.9% remains healthy for its business model. Margins are volatile quarter-to-quarter, with operating income swinging from positive $24.4 million in Q3 2024 to negative $7.9 million in Q1 2025, indicating challenges in translating high revenue growth into stable bottom-line results. The balance sheet and cash flow position is mixed; the company maintains a solid current ratio of 2.53 and a manageable debt-to-equity ratio of 0.59, but its return on equity is a modest 3.85% and return on assets is negative at -0.32%. While the company generated positive free cash flow of $75.1 million on a TTM basis, the price-to-cash-flow ratio of 216.05 is extremely high, suggesting the market is pricing in significant future cash flow growth rather than rewarding current generation, leaving it dependent on external financing for aggressive expansion.
Quarterly Revenue
$796724000.0B
2025-12
Revenue YoY Growth
+0.38%
YoY Comparison
Gross Margin
+0.57%
Latest Quarter
Free Cash Flow
$75081000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXON Overvalued?
Given the company's minimal net income ($3.0 million in Q4 2025), the primary valuation metric selected is the Price-to-Sales (PS) ratio, as profitability metrics are not yet meaningful or stable. The trailing PS ratio is an elevated 16.43x, while the forward-looking EV/Sales is 11.98x, with the gap suggesting analysts expect some revenue multiple compression or significant sales growth to justify the current price. Compared to industry averages, the valuation is challenging to contextualize precisely without a provided sector PS average, but the stock's own historical PS band provides critical insight: the current PS of 16.43x is near the middle of its own historical range observed in the data, which has seen extremes from the mid-20s down to the mid-30s in recent quarters. Trading near the midpoint of its historical valuation range suggests the market is neither excessively optimistic nor pessimistic, but rather pricing in a continuation of its current growth trajectory amid heightened uncertainty. The historical context is crucial, as the stock's own trailing PE ratio has swung wildly from over 3,800x to negative values in recent quarters, rendering the PE useless and underscoring why sales-based metrics are the only reliable gauge, with the current level implying growth expectations have moderated significantly from prior peaks.
PE
365.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -6436x~3805x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
236.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on Axon's inability to translate high revenue growth into stable profits. With a net margin of just 0.38% in Q4 2025 and operating income swinging dramatically quarter-to-quarter, the company exhibits significant earnings volatility. The extremely high price-to-cash-flow ratio of 216.05 indicates the market is pricing in massive future cash flow growth, making the stock vulnerable to any growth deceleration. Furthermore, the company's return on assets is negative at -0.32%, suggesting inefficient use of capital to generate earnings.
Market & Competitive Risks are elevated due to Axon's premium valuation and high market correlation. The trailing PS ratio of 16.43x, while near the midpoint of its own historical range, is likely at a significant premium to broader industrials or defense peers, creating compression risk if growth stocks fall out of favor. The stock's beta of 1.605 confirms it is over 60% more volatile than the market, magnifying downside during broad sell-offs. External threats include rising privacy concerns impacting the tech sector, as seen with Amazon's Ring, which could spill over to public safety technology and invite regulatory scrutiny.
Worst-Case Scenario involves a continuation of the current downtrend catalyzed by a growth scare or margin disappointment. If Q4's thin 0.38% net margin fails to improve and revenue growth decelerates from the 38.5% YoY pace, the high-multiple stock could face a severe de-rating. A specific chain could be: Q2 2026 earnings miss on margins -> analyst downgrades from current 'Overweight' stances -> multiple compression from 16.43x PS toward historical lows -> breach of the 52-week low of $396.41. Realistic downside from the current $412.81 could reach -35% to -50%, retesting lows near $250-$300, implied by a PS multiple compressing to 8-10x on stalled growth, representing a loss of roughly $145-$210 per share.
FAQ
The key risks are, in order of severity: 1) Valuation & Multiple Compression Risk: The high PS ratio of 16.43x leaves the stock exposed to de-rating if growth slows. 2) Profitability Risk: Inconsistent and minimal earnings (0.38% net margin) challenge the investment thesis. 3) Technical & Volatility Risk: The stock is in a severe downtrend with a beta of 1.605, indicating magnified downside in market sell-offs and a maximum drawdown of -54.11%. 4) Sector-Specific Risk: Potential regulatory or public backlash against surveillance-adjacent AI technology, as seen with other tech firms, could impact sentiment.
The 12-month forecast is highly bifurcated. The base case (50% probability) sees the stock trading between $450 and $550 as it digests its severe decline, with growth continuing but profitability improving slowly. The bull case (25% probability) targets $650-$750, requiring successful margin expansion and AI narrative acceleration. The bear case (25% probability) warns of a drop to $300-$396 if growth decelerates or support breaks. The most likely scenario is the base case of volatile, range-bound action, as the stock's valuation already reflects its growth, leaving limited near-term catalysts for a major rally.
AXON appears fairly valued to slightly overvalued based on current fundamentals. Its trailing Price-to-Sales (PS) ratio of 16.43x is near the midpoint of its own historical range, suggesting the market is pricing in its strong 38.5% revenue growth but also its profitability challenges. Compared to likely industry peers in industrials/defense, this multiple is almost certainly a premium. The valuation implies the market expects near-perfect execution: sustained high growth and a rapid expansion of currently thin profit margins (0.38% net margin). Any stumble makes the stock vulnerable to significant multiple compression.
AXON is a high-risk, high-potential reward investment that is not a good buy for most investors at the current price of $412.81. For aggressive growth investors with a 3-5 year horizon, it could be a speculative buy on further weakness, but the severe technical downtrend (down 42% in 6 months), extreme valuation (PS ratio of 16.43x), and lack of consistent profitability create a poor near-term risk/reward profile. The biggest downside risk is a break below the $396 support, which could trigger another leg down. It may become a good buy if the PS ratio compresses below 12x while growth remains above 30%.
AXON is strictly suitable for long-term investment with a minimum horizon of 3-5 years. Its high beta of 1.605 and extreme price swings make it a poor candidate for short-term trading. The investment thesis is based on a multi-year narrative of capturing the public safety AI market, which will take time to unfold and monetize. The company does not pay a dividend and lacks earnings stability, eliminating it as an income play. Only investors who can withstand significant volatility and are willing to wait for the profitability story to develop should consider a position.